Designing a playbook for combination and digital health trials
Ahead of the OCT Southern California event, AbbVie’s James Wabby discusses playbooks for combination and digital health trials.
By
Chris Lo
Latest articles
All Articles
The accelerating use of virtual trials – have your say in our survey
Have your say in GlobalData’s survey on the state of decentralised and virtual clinical trials during Covid-19 and beyond.
By
Covid-19: lessons learned across the life sciences
After more than a year since the emergence of Covid-19, the global road to recovery will be a long…
By
A case for streamlined RFIs in the pharmaceutical industry
External suppliers are used extensively throughout the pharma industry, but how can new client-supplier relationships be managed and defined…
By
Virtual trials: welcome to the present
With Covid-19 delivering a great big slap in the face to ongoing and planned studies, the future of clinical…
By
The impact of Covid-19 on the global clinical supply chain
It goes without saying that the coronavirus pandemic has had an unprecedented impact on economies and industries worldwide, but…
By